Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.
Mol Pharm. 2023 Oct 2;20(10):4826-4847. doi: 10.1021/acs.molpharmaceut.3c00330. Epub 2023 Sep 18.
Mol Pharm. 2023.
PMID: 37721387
Free PMC article.
Review.
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Le Gall CM, van der Schoot JMS, Ramos-Tomillero I, Khalily MP, van Dalen FJ, Wijfjes Z, Smeding L, van Dalen D, Cammarata A, Bonger KM, Figdor CG, Scheeren FA, Verdoes M.
Le Gall CM, et al. Among authors: wijfjes z.
Bioconjug Chem. 2021 Feb 17;32(2):301-310. doi: 10.1021/acs.bioconjchem.0c00673. Epub 2021 Jan 21.
Bioconjug Chem. 2021.
PMID: 33476135
Free PMC article.
Item in Clipboard
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.
van Elsas MJ, van der Schoot JMS, Bartels A, Steuten K, van Dalen D, Wijfjes Z, Figdor CG, van Hall T, van der Burg SH, Verdoes M, Scheeren FA.
van Elsas MJ, et al. Among authors: wijfjes z.
Int J Mol Sci. 2022 Aug 5;23(15):8707. doi: 10.3390/ijms23158707.
Int J Mol Sci. 2022.
PMID: 35955841
Free PMC article.
Item in Clipboard
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
Le Gall C, Cammarata A, de Haas L, Ramos-Tomillero I, Cuenca-Escalona J, Schouren K, Wijfjes Z, Becker AMD, Bödder J, Dölen Y, de Vries IJM, Figdor CG, Flórez-Grau G, Verdoes M.
Le Gall C, et al. Among authors: wijfjes z.
J Immunother Cancer. 2022 Apr;10(4):e004309. doi: 10.1136/jitc-2021-004309.
J Immunother Cancer. 2022.
PMID: 35428705
Free PMC article.
Item in Clipboard
Cite
Cite